At the recent ISPOR annual meeting in Atlanta, one of the most highly attended sessions, "Emerging Landscape of Health Economic Evaluation in the Era of Generative AI," captivated attendees with its forward-thinking discussion on the integration of generative AI in health economics.
Join Value Analytics Labs at ISPOR US from May 5-8, 2024. At ISPOR 2024, attendees will delve into the latest methodologies, data analytics, and evidence-based approaches that drive transformative changes in health and well-being. This year’s meeting is themed HEOR: A Transformative Force for Whole Health
The advent of General Artificial Intelligence (Gen AI) promises a seismic shift in the pharmaceutical industry. With its capability to automate tasks, enhance decision-making, and improve customer experiences, Gen AI stands at the forefront of a technological revolution.
When it comes to health economic modeling, the way we estimate patient survival is crucial for determining the cost-effectiveness of healthcare interventions. Traditionally, this has been done using general population mortality statistics to predict future survival rates. But is this approach still valid in a world where healthcare is rapidly advancing?
An episode on The Geo-Analyzer that Value Analytics Labs developed in collaboration with Seagen is posted on Gynecologic Oncology's website.
In collaboration with Seagen, we developed Cervical Cancer Geo-Analyzer, an open access, web-based, interactive tool to visualize geographical areas in the US where cervical cancer education or healthcare resource needs are high. The tool was launched at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting.
©2024 Value Analytics Labs. All rights reserved | Terms of Service | Privacy Policy | Design by 9piksel
